$AYLA Ayala Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ayala Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ayala Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Ayala Pharmaceuticals, Inc. for free.
IRS Number: 823578375
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: AYLA
Company Address: 1313 N. MARKET STREET SUITE 5100 WILMINGTON 19801
Ayala Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | AYLA | Ayala Pharmaceutic ... | Gordon Gary B. | Chief Medical Offic ... | Option Exercise | M | 5.16 | 3,000 | 15,480 | 89,000 | |
| Feb 26 2021 | AYLA | Ayala Pharmaceutic ... | Gordon Gary B. | Chief Medical Offic ... | Sell | S | 17.46 | 3,000 | 52,385 | 8,520 | 11.5 K to 8.5 K (-26.04 %) |
| Feb 26 2021 | AYLA | Ayala Pharmaceutic ... | Gordon Gary B. | Chief Medical Offic ... | Buy | M | 5.16 | 3,000 | 15,480 | 11,520 | 8.5 K to 11.5 K (+35.21 %) |
| Feb 24 2021 | AYLA | Ayala Pharmaceutic ... | Mamluk Roni | President & CEO | Sell | S | 17.40 | 10,800 | 187,919 | 145,345 | 156.1 K to 145.3 K (-6.92 %) |
| Feb 24 2021 | AYLA | Ayala Pharmaceutic ... | Mamluk Roni | President & CEO | Sell | S | 17.89 | 7,126 | 127,483 | 156,145 | 163.3 K to 156.1 K (-4.36 %) |
| Feb 24 2021 | AYLA | Ayala Pharmaceutic ... | Mamluk Roni | President & CEO | Sell | S | 19.86 | 15,200 | 301,813 | 163,271 | 178.5 K to 163.3 K (-8.52 %) |
| Jan 22 2021 | AYLA | Ayala Pharmaceutic ... | Mamluk Roni | President & CEO | Sell | S | 15.04 | 1,406 | 21,147 | 178,471 | 179.9 K to 178.5 K (-0.78 %) |
| Jan 22 2021 | AYLA | Ayala Pharmaceutic ... | Mamluk Roni | President & CEO | Sell | S | 15.03 | 19,466 | 292,533 | 179,877 | 199.3 K to 179.9 K (-9.77 %) |
| Jan 22 2021 | AYLA | Ayala Pharmaceutic ... | Gordon Gary B. | Chief Medical Offic ... | Option Exercise | M | 5.16 | 3,000 | 15,480 | 92,000 | |
| Jan 22 2021 | AYLA | Ayala Pharmaceutic ... | Gordon Gary B. | Chief Medical Offic ... | Sell | S | 15.03 | 3,000 | 45,084 | 8,520 | 11.5 K to 8.5 K (-26.04 %) |
| Jan 22 2021 | AYLA | Ayala Pharmaceutic ... | Gordon Gary B. | Chief Medical Offic ... | Buy | M | 5.16 | 3,000 | 15,480 | 11,520 | 8.5 K to 11.5 K (+35.21 %) |
| Aug 20 2020 | AYLA | Ayala Pharmaceutic ... | Bisker-Leib Vered | Director | Option Exercise | A | 10.98 | 8,750 | 96,075 | 8,750 | |
| May 14 2020 | AYLA | Ayala Pharmaceutic ... | Harel Insurance Co LTD | 10% Owner | Option Exercise | C | 0.00 | 211,757 | 0 | 0 | |
| May 14 2020 | AYLA | Ayala Pharmaceutic ... | Harel Insurance Co LTD | 10% Owner | Option Exercise | C | 0.00 | 307,692 | 0 | 0 | |
| May 14 2020 | AYLA | Ayala Pharmaceutic ... | Harel Insurance Co LTD | 10% Owner | Buy | P | 15.00 | 500,000 | 7,500,000 | 2,163,834 | 1.7 M to 2.2 M (+30.05 %) |